Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myeloma (COBRA)
Clinical trial NCT03729804 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03729804
- Sponsor
- University of Chicago
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-07
- Primary completion
- 2026-12-28
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.